Skip to content

A multicenter, prospective cohort design and Phase IV clinical study of Xiaoer Jingxing Zhike Granules in the treatment of infective cough in children based on real medical environment

A multicenter, prospective cohort design and Phase IV clinical study of Xiaoer Jingxing Zhike Granules in the treatment of acute bronchitis and infective cough in children based on real medical environment

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086123
Enrollment
Unknown
Registered
2024-06-25
Start date
2024-06-26
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postinfectious cough in children

Interventions

Exposure group:Conventional treatment + Xiaoer Jingxing Zhike granules

Sponsors

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 14 Years

Inclusion criteria

Inclusion criteria: (1) Meet PIC Western medical diagnostic criteria; (2) Meet the standard of TCM syndrome differentiation of cough "wind-cold turning heat syndrome"; (3) Have a history of upper respiratory tract infection, cough duration of 2 to 5 weeks (< 6 weeks); (4) Age 3-14 years old (< 15 years old).

Exclusion criteria

Exclusion criteria: (1) pertussis, influenza, measles and other acute infectious diseases; (2) suppurative tonsillitis, laryngitis, pulmonary abscess, pulmonary tuberculosis and other respiratory diseases; (3) Cough variant asthma, upper airway cough syndrome, psychogenic cough and other chronic cough; (4) People who are allergic to investigational drugs or their ingredients.

Design outcomes

Primary

MeasureTime frame
Cough resolution rate/time;

Secondary

MeasureTime frame
Curative effect of TCM syndrome;

Countries

China

Contacts

Public ContactXinmin Li

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

1510196908@qq.com+86 153 0341 7826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026